EUVIMEDEUVIMED entdecken
Multizentrische Studie

First United States multicenter experience with the new-generation FRED X surface-modified flow diversion stent: feasibility, safety, and short-term efficacy

Rawad Abbas, Matthews Lan, Kareem El Naamani, Elias Atallah, Mohamed Salem, Jan-Karl Burkhardt, Anna Luisa Kühn, Ajit Puri, Andre Monteiro, Elad I Levy, Nabeel A Herial, M Reid Gooch und 3 weitere

Journal of Neurosurgery · 2024

DOI: 10.3171/2023.7.jns23966 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neurosurgery, 2024. Verfasst von Rawad Abbas und 14 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia. Hauptthemen laut MEDLINE: Endovascular Procedures, Intracranial Aneurysm, Embolization, Therapeutic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Flow diversion created a paradigm shift in the treatment of intracranial aneurysms. The new flow redirection endoluminal device with X technology (FRED X) is the latest update of the recent Food and Drug Administration–approved FRED. The FRED X is engineered to reduce material thrombogenicity and enhance vessel healing. In this study, the authors aimed to evaluate the feasibility and early safety and efficacy of the new FRED X. METHODS The authors retrospectively collected and analyzed data from patients who had undergone flow diversion with the new FRED X at four tertiary cerebrovascular centers in the United States from February 2022 through July 2022. RESULTS Forty-four patients with 45 aneurysms treated using 46 devices comprised the overall study cohort and were divided into two groups: 39 patients with unruptured aneurysms and 5 patients with ruptured aneurysms. The mean patient age was 57.7 ± 9.1 years, and most patients were female (84%). Ninety-one percent of the aneurysms were saccular, with the majority (93%) located in the anterior circulation, specifically the posterior communicating (27%) and carotid ophthalmic (27%) territories. The mean maximum aneurysm diameter was 5.6 ± 4.6 mm, and 20% of the lesions had been previously treated. The mean procedure time was 61.6 minutes, with a mean cumulative fluoroscopy time of 24.6 minutes. Additionally, 7% of the lesions received adjunct treatment. Stent placement was successful in 100% of cases, achieving good wall apposition and complete neck coverage. Further, immediate aneurysm contrast stasis > 90% was observed in 61% of cases. Symptomatic postoperative complications occurred in 3 patients in the unruptured cohort and 1 patient in the ruptured cohort. All patients in the study were discharged on dual antiplatelet regimens with a modified Rankin Scale score of 0. At 6 months after treatment, 89% of cases had adequate occlusion, with < 6% of cases having asymptomatic in-stent stenosis. All patients had excellent functional outcomes. CONCLUSIONS FRED X for the treatment of an intracranial aneurysm is technically feasible alone or in conjunction with intrasaccular embolization. In addition, the study results showed very promising early safety and efficacy. Follow-up studies should establish the long-term safety and efficacy profiles of this new stent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endovascular ProceduresIntracranial AneurysmEmbolization, TherapeuticHumansFemaleMiddle AgedAgedMaleRetrospective StudiesTreatment OutcomeFeasibility StudiesStents

Stichwörter der Autor:innen

FRED Xaneurysmangiographyendovascular neurosurgeryflow diversionflow diverter stentsurface modificationvascular disorders

Autor:innen und Institutionen

  • 1Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia.
  • 2Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania.
  • 3Department of Neurosurgery, University of Massachusetts, Boston, Massachusetts.
  • 4Department of Neurosurgery, University of Buffalo, Buffalo, New York; and.
  • 5Germantown Friends School, Philadelphia, Pennsylvania.

Zitieren

APA

Abbas, R., Lan, M., Naamani, K. E., Atallah, E., Salem, M., Burkhardt, J. K., Kühn, A. L., Puri, A., Monteiro, A., Levy, E. I., Herial, N. A., Gooch, M. R., Jabbour, J., Rosenwasser, R., & Tjoumakaris, S. I. (2024). First United States multicenter experience with the new-generation FRED X surface-modified flow diversion stent: feasibility, safety, and short-term efficacy. Journal of Neurosurgery. https://doi.org/10.3171/2023.7.jns23966

Vancouver

Abbas R, Lan M, Naamani KE, Atallah E, Salem M, Burkhardt JK, et al. First United States multicenter experience with the new-generation FRED X surface-modified flow diversion stent: feasibility, safety, and short-term efficacy. Journal of Neurosurgery. 2024. doi:10.3171/2023.7.jns23966

BibTeX
@article{Abbas2024,
  author = {Abbas, Rawad and Lan, Matthews and Naamani, Kareem El and Atallah, Elias and Salem, Mohamed and Burkhardt, Jan-Karl and Kühn, Anna Luisa and Puri, Ajit and Monteiro, Andre and Levy, Elad I and Herial, Nabeel A and Gooch, M Reid and Jabbour, Jeffrey and Rosenwasser, Robert and Tjoumakaris, Stavropoula I},
  title = {First United States multicenter experience with the new-generation FRED X surface-modified flow diversion stent: feasibility, safety, and short-term efficacy},
  journal = {Journal of Neurosurgery},
  year = {2024},
  doi = {10.3171/2023.7.jns23966}
}
Kostenlos starten →